Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN112739683B reveals a novel Brivaracetam synthesis using Quinine catalysts. This method offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel Rh-catalyzed method for 1,3-benzodiazepines with anticancer activity. Efficient route for pharmaceutical intermediates offering cost reduction.
Novel one-step synthesis reduces cost and steps for high-purity pharmaceutical intermediates supply chain optimization and commercial scale production.
Patent CN114181132A reveals a novel high-purity synthesis route for nintedanib intermediates, offering significant cost reduction and supply chain reliability for API manufacturing.
Novel condensation route for Anserine intermediate CN112624977A offers high purity and scalable manufacturing for food and pharma applications.
Patent CN102781948A details stable P-chiral aminodiphosphine ligands enabling high-ee asymmetric hydrogenation for cost-effective chiral pharmaceutical intermediates manufacturing.
Patent CN111574487B details a novel asymmetric hydrogenation method for producing high-purity chiral dihydroisoflavones, offering significant supply chain and cost advantages.
Patent CN105111217A details copper-catalyzed one-pot synthesis offering high purity and efficient supply chain solutions for global pharmaceutical intermediate manufacturing partners.
Novel beta-site nucleophilic substitution method disclosed in patent. High selectivity, mild conditions. Reliable supply chain for fluorine intermediates manufacturing.
Patent CN104193628A reveals a novel one-step synthesis for amino aryl ketones. Discover cost-effective manufacturing and reliable supply chain solutions for high-purity intermediates.
Novel one-pot synthesis method for β-phosphorylated nitrate esters offering high yield and mild conditions for scalable pharmaceutical intermediate manufacturing.
Patent CN110669089B details a novel synthesis of 6-ketoestradiol from fermentation-derived precursors, offering high purity and reduced environmental impact for API manufacturing.
Novel furandione route offers 60.9% yield and 99.5% purity for obesity drug intermediate, ensuring scalable supply chain solutions.
Patent CN103130811B reveals efficient cascade synthesis for pharmaceutical intermediates. This method offers significant cost reduction and supply chain reliability for global buyers.
Novel phosphoramidite ligands offer high ee values and scalable synthesis for pharmaceutical intermediates manufacturing with significant cost advantages.
Patent CN110423261B reveals a novel synthesis route for 7-ketolithocholic acid from hyocholic acid, offering high purity and significant cost reduction in bile acid manufacturing.
Advanced preparation of alpha,alpha,alpha',alpha'-tetramethyl-5-(succinimide-1-methyl)-1,3-benzenediacetonitrile via integrated synthesis for precise pharmaceutical quality control.
Novel amide solvent method enhances purity and yield for Vildagliptin manufacturing, offering significant supply chain stability and cost reduction benefits.
Patent CN103588709B reveals solvent-free Edaravone synthesis. High purity >98% yields ensure cost reduction in API manufacturing and supply chain stability.
Patent CN110790752A reveals a metal-free acid-catalyzed route for quinoline substituted flavones, offering significant cost reduction and supply chain reliability for API manufacturing.